Clinical effect of defocus incorporated multiple segments (DIMS) spectacles combined with low-concentration atropine in fast-progressing myopic children

Jianjiang Xu,Qian Hao

DOI: https://doi.org/10.21203/rs.3.rs-3201754/v1

2023-01-01

Abstract:Abstract Purpose To compare the clinical efficacy of DIMS spectacles combined with 0.01% or 0.05% atropine in fast-progressing myopic children with DIMS spectacles alone. Methods We conducted a retrospective study of 93 patients aged 8–12 years who attended the optometry clinic at Shenzhen Aier Eye Hospital between January 2021 and February 2023. The subjects were selected based on their use of DIMS spectacles alone in the first year. In the second year, the patients were divided into three groups: continued to use DIMS spectacles alone (S Group), combined DIMS spectaeles with 0.01% atropine (SA1 Group), and combined DIMS spectacles with 0.05% atropine (SA5 Group). Results After a 2-year review, it was found that there was no significant difference in the growth of myopia and axial elongation among the three groups in the first year (P = 0.91; P = 0.23). In the second year, there were no significant differences in the growth of myopia and axial elongation between the S group and the SA1 group (P = 0.50; P = 0.35). Similarly, no significant differences were found between the S group and the SA5 group (P = 0.00; P = 0.00). However, significant differences were observed between the SA1 group and the SA5 group (P = 0.00; P = 0.00). Conclusions For children with rapid myopia growth using DIMS spectacles alone, the effects of combining 0.01% atropine were not obvious. However, when combined with 0.05% atropine, the effects were noticeable.